What Nutra Pharma Corp's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 1 | 1 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
Common stock only — 1 reported trade in the last 12 months is in a security these totals do not cover.
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Deitsch Rik J | 10% owner | Aug 21 | Gift · G | −12,000,000 | — | — | 0 |
| Deitsch Rik J | President, CEO | Nov 15 | Open-market buy · P | +9,000,000 | — | — | 12,000,000 |
| Deitsch Rik J | President, CEO | Nov 15 | Open-market buy · P | +3,000,000 | — | — | 3,000,000 |
| Deitsch Rik J | President, CEO | Dec 19 | Open-market buy · P | +15,000,000 | $0.01 | +$75K | 43,298,859 |
| Deitsch Rik J | President, CEO | Jul 05 | Open-market buy · P | +15,000,000 | $0.01 | +$101K | 28,298,859 |
| Deitsch Rik J | President, CEO | Jun 28 | Grant / award · A | +4,000,000 | $0.01 | +$54K | 13,298,859 |
| Deitsch Rik J | President, CEO | Jun 13 | Grant / award · A | +4,000,000 | $0.19 | +$740K | 9,298,859 |
| Deitsch Rik J | President, CEO | Dec 11 | Grant / award · A | +506,900 | $0.24 | +$122K | 5,298,859 |
| Deitsch Rik J | President, CEO | Apr 10 | Open-market buy · P | +1,250,000 | $0.08 | +$100K | 4,791,959 |
| Rumph Harold Henry | President - ReceptoPharm | Nov 25 | Grant / award · A | +7,400,000 | $0.01 | +$104K | 35,000,000 |
| Pottruck Garry | Director | Nov 25 | Grant / award · A | +6,890,000 | $0.01 | +$96.5K | 17,815,000 |
| Deitsch Rik J | President, CEO | Nov 25 | Grant / award · A | +11,760,000 | $0.01 | +$165K | 141,678,334 |
| Lonky Stewart Alan | Director | Oct 18 | Disposition to Issuer · D | +70,000 | $0.01 | +$560 | 20,220,000 |
| Rumph Harold Henry | President - ReceptoPharm | Sep 09 | Open-market buy · P | +14,800,000 | $0.00 | +$37K | 27,600,000 |
| Deitsch Rik J | President, CEO | Sep 09 | Open-market buy · P | +25,000,000 | $0.00 | +$62.5K | 129,918,334 |
| Deitsch Rik J | President, CEO | Jun 27 | Open-market buy · P | +25,000,000 | $0.00 | +$100K | 104,918,334 |
| Lonky Stewart Alan | Director | Mar 08 | Grant / award · A | +7,730,000 | — | — | 20,150,000 |
| Deitsch Rik J | President, CEO | Dec 19 | Open-market buy · P | +10,000,000 | $0.01 | +$100K | 79,918,334 |
| Deitsch Rik J | President, CEO | Dec 10 | Open-market buy · P | +200,000 | $0.01 | +$2.98K | 69,918,334 |
| Lonky Stewart Alan | Director | Oct 18 | Grant / award · A | +5,000,000 | — | — | 12,420,000 |
Loading...
